Lariago DS Tablet
5 Tablet(s) in StripMRP ₹18.79
₹15.60
17% OFF
Made by
IPCA LABORATORIES
Dosage
TABLET
Expiry
Product Summary
| Salt Content | Chloroquine(500.0 Mg) |
| Uses | Malarial infection |
| Therapy | Anti-malarial |
| Side effects | Headache, nausea, vomiting, rashes, itching |
Assurance
available
Regulated
Medical Description
Lariago-DS tablet is an effective medicine used for the treatment and prevention of malaria. It contains chloroquine as its active ingredient that works by killing the parasitic organism responsible for causing malaria. Common symptoms of malaria include fever, flu-like illness, shakiness, chills, headache, muscle pain, and tiredness. If left untreated, malaria can cause kidney failure, seizures, mental confusion, coma, and even death. Therefore, it's important to take Lariago-DS as directed by your doctor, in the prescribed doses and duration, and after food to avoid an upset stomach. Even if you start feeling better after taking this medicine, do not stop taking it without consulting your doctor. Stopping this medicine suddenly may result in treatment failure and incomplete eradication of malaria-causing organisms from the body, increasing the risk of re-infection. It's important to inform your doctor if you are pregnant, planning a pregnancy, or breastfeeding, and about all the medicines and supplements you take and all the conditions or diseases you suffer from before starting Lariago-DS.
Uses
Contraindications
- If you are allergic to chloroquine or any other ingredients of Lariago-DS tablet.
- If you are taking Amiodarone to control irregular heartbeats.
Side effects
- Headache
- Nausea
- Vomiting
- Rashes
- Itching
- Loss of appetite
- Diarrhoea
- Stomach pain
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You experience a sudden drop in blood sugar and unconsciousness, extreme hunger, headache, nausea, vomiting, sleepiness, restlessness, aggression, reduced alertness, confusion, shakiness or dizziness.
- You are experiencing chest pain, irregular heart rhythm, increased heart rate or palpitations.
- You have swelling in the legs, breathlessness, fatigue, bloating or coughing while lying.
- You have liver, kidney and heart disorders & muscle weakness.
- You have developed rashes after taking this medicine.
- You have a history of an autoimmune disorder of the skin called porphyria.
- You are supposed to take a Lariago-DS tablet for long-term treatment. Then you should be monitored for heart muscle disorder.
- You have a blood enzyme deficiency (glucose-6-phosphate dehydrogenase deficiency).
- You must avoid being in the sunlight for too long, as the Lariago-DS tablet may make you more sensitive to the sun.
Directions for Use
Storage and disposal
- Store Lariago-DS tablets below 30°C in a clean and dry place.
- Keep it away from children and pets.
Quick Tips
- Lariago-DS is an antimalarial medicine. It is used to treat, prevent & suppress malarial infection. It contains chloroquine as the active ingredient.
- Complete the course given by your doctor, even if you start feeling better after taking this medicine. Missing a dose or stopping this medicine can cause treatment failure.
- Lariago-DS tablet must be taken exactly in the doses and duration prescribed by the doctor. It's best to take it after meals to avoid stomach discomfort.
- Before starting Lariago-DS tablet, inform your doctor if you are pregnant, planning on becoming pregnant or breastfeeding. Also, inform your doctor about all other medicines that you take and your complete medical history.
- Do not take any medicine on your own without confirming with your doctor during treatment with this medicine.
- Headache, stomach ache, diarrhoea and nausea/vomiting may occur in some individuals with the use of this medicine. Inform your doctor if these effects bother you or do not go away.
- If you experience dizziness or sleepiness after taking Lariago-DS tablet, it is recommended to avoid driving, operating heavy machinery or performing any such tasks that require mental alertness.
Dosage
Overdose
- Overdose of Lariago-DS tablet may lead to serious conditions like a failure of blood circulation in the body, breathing dysfunction, coma or even death. Symptoms of overdose are nausea, vomiting, headache, dizziness, decrease in potassium level, blurred or double vision, uneasiness, fits, low blood pressure, shock, lung diseases and abnormal heart rate.
- If you experience any of the symptoms or if you think you have taken too much of this medicine, contact your doctor immediately or visit the nearest hospital.
Missed a Dose
Mode of Action
How Does It Work?
Interactions
Interactions with other medicines
- Lariago-DS tablet may interact with other medicines, discuss with your doctor about all the medicines, supplements, or herbal preparations you are taking. Also, you should inform your doctor if you have a planned surgery or vaccination scheduled.
- Be cautious if you are taking medicines for treating uneven heartbeat, medicines for mental illness. medicines to reduce the acid content in the stomach and anti-infectives.
- Other antimalarials like Halofantrine and Mefloquine as you may experience fits with Mefloquine.
- Medicine used to reduce stomach acid & to treat diarrhoea like Kaoline should be taken with a minimum gap of four hours.
- Lariago ds may reduce the effectiveness of certain vaccines like the rabies vaccine.
Interactions with food items
Frequently Asked Questions (FAQs)
Articles
View AllChronic Condition Articles
View AllDid you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:LARIAGO
Manufacturer Name:IPCA LABORATORIES
Address:Ipca Laboratories Ltd.,C-6, Sara Ind. Estate, Chakrata Road, Rampur, Dehradun-248197
Country of Origin:India
Vendor Details
Fulfillment Information: Lariago 500 MG Tablet (5) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
References:
- Avloclor Tablets - Summary of Product Characteristics (SmPC) - (emc) [Internet]. Medicines.org.uk. 2021 [cited 5 April 2022]
- ARALEN [Internet]. Accessdata.fda.gov. 2021 [cited 5 April 2022]
- Chloroquine [Internet]. Ncbi.nlm.nih.gov. 2021 [cited 5 April 2022]
- Avloclor Tablets - Patient Information Leaflet (PIL) - (emc) [Internet]. Medicines.org.uk. 2021 [cited 5 April 2022]
- Chloroquine. In: MedlinePlus [Internet]. U.S. National Library of Medicine; [updated 2025 Jan 23].
- Chloroquine. In: DrugBank [Internet]. [cited 2025 Jan 23].
- National Center for Biotechnology Information (2025). PubChem Compound Summary for CID 2719, Chloroquine. Retrieved January 23, 2025
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.





















